Tag: Health Care

Displaying 21 - 40 of 802 results.

Supplement marketers i-Health, Inc. and Martek Biosciences Corporation have agreed to settle FTC charges of deceptive advertising for claiming that their BrainStrong Adult dietary supplement will improve adult memory and prevent cognitive decline.
The Federal Trade Commission has charged personal care company Lornamead, Inc. with deceiving consumers with exaggerated claims that its “Lice Shield” shampoo, stick, and spray products  will prevent or reduce the risk of getting head lice. Under an agreed-upon settlement, Lornamead will pay $500,...
The Federal Trade Commission has sued a Florida-based operation that capitalized on the green coffee diet fad by using bogus weight loss claims and fake news websites to market the dietary supplement Pure Green Coffee. Popularized on the syndicated talk show The Dr. Oz Show, green coffee bean...
Following a public comment period, the Federal Trade Commission has approved final consent orders settling charges that two marketers of genetically customized nutritional supplements deceptively advertised that their personalized nutritional supplements treat diabetes, heart disease, arthritis,...
Brief of the Federal Trade Commission as Amicus Curiae before the United States District Court for the Eastern District of Pennsylvania, addressing whether a branded company's commitment not to launch an authorized generic in competition with a generic company can constitute a...
Federal Trade Commission staff submitted written comments to Missouri State Representative Jeanne Kirkton in response to a request for comments on legislative proposals that would remove or change requirements for “collaborative practice arrangements” between Missouri physicians and Advanced...
The Federal Trade Commission announced the agenda and panelists for its upcoming seminar on the privacy ramifications of consumer generated and controlled health data, taking place on May 7 from 10 a.m. to noon in Washington, D.C.
The Federal Trade Commission and the Antitrust Division of the Department of Justice held a one-day public workshop on June 23, 2014 to explore the economics and legal policy implications of certain pricing practices, such as loyalty and bundled pricing. The workshop, consisted of...
Increased competition from the Internet has raised a concern of product quality for online prescription drugs. The Food and Drug Administration (FDA) prohibits the importation of unapproved drugs into the US and the National Association of Boards of Pharmacy (NABP) emphasizes their...
Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that Community Health Systems, Inc.’s (CHS) $7.6 billion acquisition of rival health care system Health Management Associates Inc. (HMA) was likely to lessen competition for general...
Akorn Enterprises, Inc. and Hi-Tech Pharmacal, Inc. will sell the rights and assets to three generic prescription eye medications and two generic topical anesthetics to Watson Laboratories, Inc., to settle Federal Trade Commission charges that Akorn’s proposed $640 million acquisition of Hi-Tech...
Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that beauty products and cosmetics marketer L’Occitane violated the Federal Trade Commission Act with claims about the slimming properties of its Almond Beautiful Shape and Almond...
Federal Trade Commission Chairwoman Edith Ramirez released the agency’s 2013 Annual Highlights today at the Spring Meeting of the American Bar Association’s Section of Antirust Law in Washington emphasizing the agency’s work to protect consumers and promote competition during the past calendar...

Pages